- Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and li...
Minerva Neurosciences Competitors or Alternatives
Minerva Neurosciences's top competitors include Cynapsus, Sage Therapeutics and Voyager.
Minerva Neurosciences VS Sage Therapeutics
Sage Therapeutics is Minerva Neurosciences's #2 competitor. Sage Therapeutics was founded in 2010, and its headquarters is in Cambridge, Massachusetts. Sage Therapeutics competes in the Biotechnology industry. Sage Therapeutics has 681 more employees than Minerva Neurosciences.
Looking for similar companies to Minerva Neurosciences?
Similar Companies
Pharmaceuticals companies in Waltham
See 37 companies
Companies in Waltham with revenue in $25-100M rangeSee 135 companies
Pharmaceuticals & Biotechnology companies in WalthamSee 121 companies
Biotechnology companies in WalthamSee 97 companies
Companies in Waltham with employees in 1-25 rangeSee 313 companies
Pharmaceuticals companies in Greater BostonSee 500 companies
Pharmaceuticals companies in MassachusettsSee 516 companies
Pharmaceuticals companies with revenue in $25-100M rangeSee 827 companies
Biotechnology companies with revenue in $25-100M rangeSee 854 companies
Trending News for Minerva Neurosciences and Minerva Neurosciences's Competitors
Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial. The post Vertex halts development of...
Results support continued development in MDD with concomitant EDS; Phase 3 trial planned in 2025...
AMSTERDAM & BOSTON-(BUSINESS WIRE)-VectorY Therapeutics, a biotechnology company advancing vectorized antibody therapies for neurodegenerative diseases...
NEW YORK, March 31, 2025 /PRNewswire/ - Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. ("Sarepta" or the "C...
Novartis announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for patients with prostate─...
Bluebird Bio Inc. (NASDAQ: BLUE) shares are trading higher Monday after the company received an unsolicited takeover offer from Ayrmid Ltd. read more...
REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of ge...
Vertex Pharmaceuticals is stopping development of VX-264, an experimental cell therapy/medical device treatment for type 1 diabetes, after an early loo...
Novartis has scored a win in Korea's reimbursement system, clearing its immunosuppressant Cosentyx (secukinumab) for use in children and teens with chr...
Frequently Asked Questions about Minerva Neurosciences
Who are Minerva Neurosciences's top competitors?
Minerva Neurosciences's top 3 competitors are Cynapsus, Sage Therapeutics, Voyager.Who is similar to Minerva Neurosciences?
Cynapsus is the most similar to Minerva Neurosciences. Sage Therapeutics and Voyager are also similar to Minerva Neurosciences.
Are Minerva Neurosciences and Cynapsus competitors?
Yes, Cynapsus is one of Minerva Neurosciences’s top competitors.